These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30677774)

  • 61. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
    Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
    J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia.
    Wolf G; Schroeder R; Thaiss F; Ziyadeh FN; Helmchen U; Stahl RA
    Kidney Int; 1998 Apr; 53(4):869-79. PubMed ID: 9551393
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cells.
    Gu J; Wen Y; Mison A; Nadler JL
    Endocrinology; 2003 Feb; 144(2):534-43. PubMed ID: 12538614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diabetic rat glomerular mesangial cells display normal inositol trisphosphate and calcium release.
    Hurst RD; Whiteside CI; Thompson JC
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F649-55. PubMed ID: 1415736
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
    Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
    Mori J; Patel VB; Ramprasath T; Alrob OA; DesAulniers J; Scholey JW; Lopaschuk GD; Oudit GY
    Am J Physiol Renal Physiol; 2014 Apr; 306(8):F812-21. PubMed ID: 24553436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats.
    Wolf G; Wenzel U; Ziyadeh FN; Stahl RA
    Diabetologia; 1999 Dec; 42(12):1425-32. PubMed ID: 10651261
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.
    Ibrahim AS; Saleh H; El-Shafey M; Hussein KA; El-Masry K; Baban B; Sheibani N; Wang MH; Tawfik A; Al-Shabrawey M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):636-645. PubMed ID: 28351645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization.
    Haruhara K; Suzuki T; Wakui H; Azushima K; Kurotaki D; Kawase W; Uneda K; Kobayashi R; Ohki K; Kinguchi S; Yamaji T; Kato I; Ohashi K; Yamashita A; Tamura T; Tsuboi N; Yokoo T; Tamura K
    Kidney Int; 2022 May; 101(5):912-928. PubMed ID: 35240129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of angiotensin II in diabetic nephropathy.
    Leehey DJ; Singh AK; Alavi N; Singh R
    Kidney Int Suppl; 2000 Sep; 77():S93-8. PubMed ID: 10997697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Critical role for osteopontin in diabetic nephropathy.
    Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
    Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction.
    Rüster C; Franke S; Wenzel U; Schmidthaupt R; Fraune C; Krebs C; Wolf G
    Am J Nephrol; 2011; 34(4):309-17. PubMed ID: 21846974
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1.
    Wolf G; Jablonski K; Schroeder R; Reinking R; Shankland SJ; Stahl RA
    Kidney Int; 2003 Jul; 64(1):71-81. PubMed ID: 12787397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
    Whiteside CI; Thompson J
    Endocrinology; 1989 Oct; 125(4):1932-40. PubMed ID: 2551633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
    Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
    Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altered prostatic epithelial proliferation and apoptosis, prostatic development, and serum testosterone in mice lacking cyclin-dependent kinase inhibitors.
    Mukai M; Dong Q; Hardy MP; Kiyokawa H; Peterson RE; Cooke PS
    Biol Reprod; 2005 Nov; 73(5):951-8. PubMed ID: 16014817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 12/15-Lipoxygenase mediates high-fat diet-induced endothelial tight junction disruption and monocyte transmigration: a new role for 15(S)-hydroxyeicosatetraenoic acid in endothelial cell dysfunction.
    Kundumani-Sridharan V; Dyukova E; Hansen DE; Rao GN
    J Biol Chem; 2013 May; 288(22):15830-42. PubMed ID: 23589307
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II.
    Sanchez-Niño MD; Sanz AB; Sanchez-Lopez E; Ruiz-Ortega M; Benito-Martin A; Saleem MA; Mathieson PW; Mezzano S; Egido J; Ortiz A
    Lab Invest; 2012 Jan; 92(1):32-45. PubMed ID: 21931298
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth.
    Somjen D; Tordjman K; Katzburg S; Knoll E; Sharon O; Limor R; Naidich M; Naor Z; Hendel D; Stern N
    Bone; 2008 Mar; 42(3):491-7. PubMed ID: 18187376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.